Gradient Investments LLC Exact Sciences Corp Transaction History

Gradient Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$41.33 - $74.26 $1,983 - $3,564	48 Added 300.0%	64 $2,000
Q1 2024 Apr 23, 2024	BUY	$56.27 - $73.77 $225 - $295	4 Added 33.33%	16 $1,000
Q3 2023 Oct 27, 2023	SELL	$65.94 - $99.04 $6,594 - $9,904	-100 Reduced 89.29%	12 $0
Q2 2023 Jul 11, 2023	BUY	$62.68 - $95.05 $752 - $1,140	12 Added 12.0%	112 $10,000
Q1 2023 Apr 17, 2023	BUY	$47.19 - $70.77 $4,719 - $7,077	100 New	100 $6,000
Q1 2020 Apr 07, 2020	SELL	$37.9 - $104.44 $75 - $208	-2 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$90.37 - $122.49 $180 - $244	2 New	2 $0

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.